title: Criteria for extra-label drug use debated at FDA Advisory Committee meeting.
authors.forename: T A
authors.initials: TA
authors.lastname: Raef
mesh_terms: D000818:Animals; D007880:Legislation, Drug; D007886:Legislation, Veterinary; D014481:United States; D014486:United States Food and Drug Administration